Featuring an interview with Dr Hanny Al-Samkari. Published April 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.75 credits
MOC types
ABIM — Medical KnowledgeUp to 0.75 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Board review / self-assessment
- includes Microlearning
- includes On-demand / recorded video
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
-
ReleasedApr 1, 2026
-
Last day to claim creditApr 3, 2027 6 months left
-
Research to Practice Practical Perspectives on the Current and Future Management of Immune Thrombocytopenia What Happened at ASH 2025? Microlearning Activity 3 | 2026 (Video Program)
-
Research to Practice Practical Perspectives on the Current and Future Management of Immune Thrombocytopenia What Happened at ASH 2025? | 2026 (Webinar Video Proceedings)
-
Research to Practice Recent Developments in the Management of R/R MM from ASH 2025: BCMA-Targeted Therapy and Investigational Agents Microlearning Activity 1 | 2026 (Video Interview)
-
PRIME Education, Inc. (PRIME®) Therapeutic Advances in Immune Thrombocytopenia: Patient-Centric Paths to Improving Long-Term Outcomes
-
Physicians’ Education Resource Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia
-
Medical Learning Institute, Inc. B-Cell-Directed Therapies in Immune Thrombocytopenia Real-World Practice
